Download in electronic PDF format for $35



Search the Complete Journal Archives

Establishing a Rationale for Compounding Hormone Replacement Therapy

Author(s):  Biundo Bruce

Issue:  May/Jun 2018 - Volume 22, Number 3
View All Articles in Issue

Abstract:  Why compound bioidentical hormones? Are there no similar commercial products? What is unique about the options compounding pharmacists offer compared with what is out in the marketplace? These are questions that physicians and other practitioners are asking, and it is very important that we have intelligent, well-thought answers when we respond. Times have changed, and the challenges we face today in marketing our compounded therapies are not the same as those of twenty years ago. Premarin is no longer at the top of the heap, and there are topical, commercial products that contain bioidentical estradiol, and capsules that contain the same progesterone that we use. Our compounding advantage comes from our abilities to prepare unique patient-specific products, and, very importantly, from our growing understanding of hormone receptors; we now know there are two main estrogen receptors, 1) estrogen receptor alpha and 2) estrogen receptor beta, and the growing knowledge base associated with the discovery of estrogen receptor beta is quite significant.

Related Keywords: Bruce Biundo, RPh, FACA, bioidentical hormone replacement therapy, women, estrogen receptor alpha, estrogen receptor beta, menopause, topical preparations, regulation, regulatory approval, estradiol, estriol, breast cancer, testosterone, mood, sexual function, female sexual dysfunction, androgens, libido, hot flashes, vasovagal syndrome, estrogen balance, hysterectomy, bone density

Related Categories: HRT, ENDOCRINOLOGY/HORMONES/ MENOPAUSE/ANDROPAUSE, INFORMATION RESOURCES

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Establishing a Rationale for Compounding Hormone Replacement Therapy Biundo Bruce May/Jun 2018 190-195 Buy
The Science Behind Hormone Replacement Therapy, Part 1 Wepfer Scott T Nov/Dec 2001 462 Buy
Bioidentical Hormone Replacement Therapy, Part 3, A Review of Wepfer Scott T Mar/Apr 2002 142 Buy
Menopausal Symptom Relief and Side Effects Experienced by Women Using Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 1 Deleruyelle Laura J Sep/Oct 2016 359-364 Buy
Menopausal Symptom Relief and Side Effects Experienced by Women Using Compounded Bioidentical Hormone Replacement Therapy and Synthetic Conjugated Equine Estrogen and/or Progestin Hormone Replacement Therapy, Part 2 Deleruyelle Laura J Nov/Dec 2016 447-454 Buy
The Effects of Compounded Bioidentical Transdermal Hormone Therapy on Hemostatic, Inflammatory, and Immune Factors; Cardiovascular Biomarkers; Quality of Life Measures; and Health Outcomes in Perimenopausal and Postmenopausal Women Stephenson Kenna, Neuenschwander Pierre F, Kurdowska Anna K Jan/Feb 2013 74-85 View Sample
A Perspective on HRT for Women: Picking Up the Pieces After the Women's Health Initiative Trial - Part 1 Gillson George R, Zava David T Jul/Aug 2003 250 Buy
Impact of Conventional and Bioidentical Hormone Replacement Therapy on Cardiovascular and Breast Health: A Review Ruiz Andres D, Daniels Kelly R, Barner Jamie C, Carson John J, Frei Christopher R Jul/Aug 2011 290-300 Buy
Efficacy and Tolerability of Compounded Bioidentical Hormone Replacement Therapy Vigesaa Kristy A, Downhour Nathan P, Chui Michelle A, Cappellini Linda, Musil John D, McCallian Dennis J Jul/Aug 2004 313-319 Buy
Efficacy and Clinical Value of Commonly Compounded Hormone Replacement Therapy: A Literature Review Beshay Sarah M, Rivera Gerard, Balthasar Jan, Florea Naomi Jan/Feb 2015 6-12 Buy